Transferring a semi-solid formulation from development to manufacturing can introduce new challenges. At Tiofarma, we are simplifying this transition by investing in matching Becomix mixing vessels across R&D and production, creating a more consistent path from process development to validated manufacturing.

Same equipment, fewer steps

In semi-solid pharmaceutical manufacturing, transferring a process from development to production often involves moving between different equipment. Changes in mixing geometry and process behaviour can require additional development work and intermediate batches before validation can begin.

To reduce this complexity, Tiofarma has invested in matching 15 L and 60 L Becomix mixing vessels for both its R&D and manufacturing facilities.

This deliberate choice allows processes to be developed using equipment that matches the intended manufacturing setup. By reducing equipment-related variables during process transfer, we create a more consistent basis for validation.

For our clients, this approach can offer several benefits:

  • Fewer intermediate development batches.
  • A shorter path from development to validated manufacturing.
  • Reduced risk associated with process transfer.
  • Greater continuity between development and commercial production.

Supporting an established product portfolio

The new vessels are already being used in the redevelopment and revalidation of manufacturing processes for around 100 products for a long-standing customer. This project is part of a broader quality improvement programme within our semi-solid manufacturing operations.

Following installation, our operators received extensive training on the new equipment, supporting a smooth transition while maintaining ongoing production.

The first validation batches have now been completed, and the first product has entered production using the new equipment.

This project demonstrates how our integrated development and manufacturing capabilities support not only new product development but also the optimisation of existing pharmaceutical products.

Connecting development and manufacturing

At Tiofarma, we see development and manufacturing as closely connected activities. By aligning our equipment, processes and expertise, we aim to simplify the transition between these stages and support efficient, reliable pharmaceutical manufacturing.

Our investment in matching Becomix equipment reflects this approach and strengthens our capabilities as a CDMO specialising in semi-solid pharmaceutical products.

Translate »